Recruiting studies: Anophthalmia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
NA · 7 location(s) · Institut Curie · NCT05475366 National Cohort on Congenital Defects of the Eye
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05954403 Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Phase 1 · 18 location(s) · Duke Street Bio Ltd · NCT06458712 CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)
Phase 1 · 1 location(s) · John Lenehan · NCT06393400 Modeling Ocular Developmental Diseases From 3D Cultures of Optic Vesicle Organoids Derived From hiPSCs of Patients With
Phase N/A · 2 location(s) · University Hospital, Toulouse · NCT06408701 Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children
Phase N/A · 1 location(s) · Baylor College of Medicine · NCT06293560 Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck
Phase 1 · 48 location(s) · AbbVie · NCT05005403 Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)
Phase N/A · 1 location(s) · National Eye Institute (NEI) · NCT01778543

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.